Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

[167] Delgado C, Bundy BN, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-
pathological study of disease free interval in patients with stage Ib squamous cell carcinoma of the
cervix: A GOG study. Gynecol Oncol 1990 ; 38 : 352-357
[168] Tinga DJ, Bouma J, Boonstra H, Aalders JG. Symptomatology, localization and treatment
of recurrent cervical carcinoma.Int J Gynecol Cancer 1992 ; 2 : 179-188
[169] Belnison Jl.,Pretorius Rg.,Zhang Wh.,Wu Ly., Qiao L., Elson P. Cervical cancer screening
by simple visual inspection after acetic acid. Obstet. Gynecol., 2001, 98, 3, 441-444
[170] Meheus A. Prevention of sexually transmitted infections through health education and
counselling: a general framework. In: Franco EL, Monsonego J (eds.) New developments in cervical
cancer screening and prevention. London: Blackwell, 1997: 84-90.
[171] Rock CL, Michael CW, Reynolds RK, Ruffin MT. Prevention of cervix cancer. Crit Rev
Oncol Hematol 2000;33:169-85.
[172] Schiller JT. Papillomavirus-like particle vaccines for cervical cancer. Mol Med Today
1999;5:209-15.
[173] Cesil Wright V., Dubuc-Lissoir J, Ehlen T, Plante M. Lignes directrices sur
l’adénocarcinome in situ du col utérin:caractéristiques cliniques et revue du traitement. Int.
J.SOGC,1999,77.
[174] Westermann Am.,El J., Steen-Banasik V.,Koper P. First results of triple-modality
treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients
with stage IIB, III and IVA cervical carcinoma. Cancer, 2005, 104(4), 763-770.
159